BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2145893)

  • 1. Absence of abnormalities of the c-erbB-1 and c-erbB-2 proto-oncogenes in human thyroid neoplasia.
    Lemoine NR; Wyllie FS; Lillehaug JR; Staddon SL; Hughes CM; Aasland R; Shaw J; Varhaug JE; Brown CL; Gullick WJ
    Eur J Cancer; 1990; 26(7):777-9. PubMed ID: 2145893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
    Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
    Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of c-myc and c-erbB-2 proto-oncogenes in human solid tumors: frequency and clinical significance.
    Gutman M; Ravia Y; Assaf D; Yamamoto T; Rozin R; Shiloh Y
    Int J Cancer; 1989 Nov; 44(5):802-5. PubMed ID: 2573579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogene profile of papillary thyroid carcinoma.
    Sugg SL; Ezzat S; Zheng L; Freeman JL; Rosen IB; Asa SL
    Surgery; 1999 Jan; 125(1):46-52. PubMed ID: 9889797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and expression of nuclear oncogenes in multi-stage thyroid tumorigenesis.
    Wyllie FS; Lemoine NR; Williams ED; Wynford-Thomas D
    Br J Cancer; 1989 Oct; 60(4):561-5. PubMed ID: 2803926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Joint amplification of c-myc and c-Ha-ras oncogenes in human breast and thyroid cancer cells].
    Pluzhnikova GF; Serova OM; Kniazev PG; Fedorov SN; Novikov LB
    Eksp Onkol; 1987; 9(2):15-7. PubMed ID: 3034547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-amplification of c-myc and c-erbB-2 oncogenes in a poorly differentiated human gastric cancer.
    Tsuchiya T; Ueyama Y; Tamaoki N; Yamaguchi S; Shibuya M
    Jpn J Cancer Res; 1989 Oct; 80(10):920-3. PubMed ID: 2575609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of the proto-oncogenes int-2, c-erb B-2 and c-myc in human breast cancer.
    Machotka SV; Garrett CT; Schwartz AM; Callahan R
    Clin Chim Acta; 1989 Oct; 184(3):207-17. PubMed ID: 2611995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA amplification of the c-myc and c-erbB-1 genes in a human stomach cancer.
    Nomura N; Yamamoto T; Toyoshima K; Ohami H; Akimaru K; Sasaki S; Nakagami Y; Kanauchi H; Shoji T; Hiraoka Y
    Jpn J Cancer Res; 1986 Dec; 77(12):1188-92. PubMed ID: 3102422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-erbB-3 protein expression in ovarian tumours.
    Simpson BJ; Weatherill J; Miller EP; Lessells AM; Langdon SP; Miller WR
    Br J Cancer; 1995 Apr; 71(4):758-62. PubMed ID: 7710941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer.
    Lemoine NR; Jain S; Silvestre F; Lopes C; Hughes CM; McLelland E; Gullick WJ; Filipe MI
    Br J Cancer; 1991 Jul; 64(1):79-83. PubMed ID: 1677259
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB.
    Aasland R; Lillehaug JR; Male R; Jøsendal O; Varhaug JE; Kleppe K
    Br J Cancer; 1988 Apr; 57(4):358-63. PubMed ID: 3390372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and amplification of the HER-2/neu (c-erbB-2) protooncogene in epithelial ovarian tumors and cell lines.
    Tyson FL; Boyer CM; Kaufman R; O'Briant K; Cram G; Crews JR; Soper JT; Daly L; Fowler WC; Haskill JS
    Am J Obstet Gynecol; 1991 Sep; 165(3):640-6. PubMed ID: 1679963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas.
    Terrier P; Sheng ZM; Schlumberger M; Tubiana M; Caillou B; Travagli JP; Fragu P; Parmentier C; Riou G
    Br J Cancer; 1988 Jan; 57(1):43-7. PubMed ID: 3348948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of the c-erbB oncogene is associated with malignancy in primary tumours of neuroepithelial tissue.
    Diedrich U; Soja S; Behnke J; Zoll B
    J Neurol; 1991 Jul; 238(4):221-4. PubMed ID: 1895152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic alterations in c-erbB-2 protooncogene as prognostic markers in human primary breast tumors.
    Nagai MA; Marques LA; Torloni H; Brentani MM
    Oncology; 1993; 50(6):412-7. PubMed ID: 7901824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Amplification and expression of oncogenes in human malignant tumors--organ or tissue specificity and prognosis].
    Ueda M; Shimizu N; Abe O
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1579-81. PubMed ID: 2573817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas.
    Park JB; Rhim JS; Park SC; Kimm SW; Kraus MH
    Cancer Res; 1989 Dec; 49(23):6605-9. PubMed ID: 2573419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma.
    Tavassoli M; Quirke P; Farzaneh F; Lock NJ; Mayne LV; Kirkham N
    Br J Cancer; 1989 Oct; 60(4):505-10. PubMed ID: 2572268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.